← Open Payments lookup

RACHEL TOWNSEND: Open Payments

NPI 1760116495 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$621 in 51 payments from 10 companies in 2025. Trend: 2023 $64 · 2024 $248 · 2025 $621

Food & beverage: $621
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.29$137
Lundbeck LLC5$130
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$116
Vanda Pharmaceuticals Inc.3$68
Otsuka America Pharmaceutical, Inc.3$64
Lilly USA, LLC2$32
Takeda Pharmaceuticals U.S.A., Inc.1$24
Tris Pharma Inc1$19
TMS NeuroHealth Centers Inc.1$16
Janssen Pharmaceuticals, Inc1$14

Products named: REXULTI, Qelbree, CAPLYTA, HETLIOZ, TRINTELLIX, Dyanavel XR, JARDIANCE, TMS NeuroHealth Centers Inc..

Industry payments across MD — which companies pay providers there.